Chronic Obstructive Pulmonary Disease. Other chronic obstructive pulmonary disease
Conditions
Interventions
Intervention 1: Intervention group: Testosterone ??Enanthate will be Injected 100 mg every 2 Weeks for 8 Courses. Intervention 2: Control group: For the Control Group, a Drug Solvent, Which is Genera
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
No minimum to 80 Years
Inclusion criteria
Inclusion criteria: All Male Patients With Chronic Obstructive Pulmonary Disease
Exclusion criteria
Exclusion criteria: Exacerbation In the Last 4 Weeks Congestive Heart Disease Sever Uncontrol Hypertention Thromboembolic Disease Coagulation Disorders Polycythemia Prostate Cancer History
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary Function test. Timepoint: Performing a pulmonary function test at the beginning of the study before the start of the intervention and 16 weeks after receiving testosterone. Method of measurement: Spirometery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Measurement of Body Mass Index at the beginning of the study before the intervention and 16 weeks after receiving testosterone. Method of measurement: Based on height and weight.;6 min-walk distance. Timepoint: Measurement of 6 min-walk distance at the beginning of the study before the intervention and 16 weeks after receiving testosteron. Method of measurement: Meter.;O2 saturation. Timepoint: Measurement of Pulse Oximetry at the Beginning of the Study Before the Intervention and 16 weeks after Receiving Testosteron. Method of measurement: Pulse Oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Mortazavi Moghadam
Arak University of Medical Sciences
Outcome results
None listed